Propriedade intelectual e pandemia de Covid-19: um estudo de caso da relação jurídica entre a Fiocruz e a AstraZeneca

Abstract

Based on the analysis of the complex agreement signed between Fiocruz/Bio-Manguinhos and Astranezeca for the production of the Covid-19 vaccine, this research aimed to better understand the limits of the current regulatory system of intellectual property in a situation of health crisis such as the Covid-19 pandemic. It is an qualitative research and a empirical single case study carried out from primary and secondary sources, guided by a critical analysis of intellectual property. Even considering the emergence of the pandemic, it was found that the alternatives proposals to the system were unsuccessful and the agreement between Fiocruz and Astrazeneca established more accordance than rupture with the current Brazilian intellectual property system. It was observed that the agreement could be seen as an extension of this system, as it followed the rules laid down in national and international legislation, that is, there was no adaptation and even less rupture with the pre-established rules.